Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

VEGFA antibody (C-Term)

This anti-VEGFA antibody is a Rabbit Polyclonal antibody detecting VEGFA in WB, IHC, ELISA and IHC (p). Suitable for Human. This Primary Antibody has been cited in 6+ publications.
Catalog No. ABIN2855448

Quick Overview for VEGFA antibody (C-Term) (ABIN2855448)

Target

See all VEGFA Antibodies
VEGFA (Vascular Endothelial Growth Factor A (VEGFA))

Reactivity

  • 168
  • 115
  • 81
  • 27
  • 26
  • 24
  • 20
  • 12
  • 7
  • 6
  • 5
  • 5
  • 3
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
Human

Host

  • 214
  • 80
  • 12
  • 2
  • 2
  • 1
Rabbit

Clonality

  • 222
  • 86
  • 2
Polyclonal

Conjugate

  • 169
  • 44
  • 27
  • 10
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This VEGFA antibody is un-conjugated

Application

  • 239
  • 107
  • 94
  • 65
  • 55
  • 40
  • 40
  • 32
  • 23
  • 16
  • 15
  • 12
  • 10
  • 10
  • 8
  • 8
  • 3
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
Western Blotting (WB), Immunohistochemistry (IHC), ELISA, Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
  • Binding Specificity

    • 29
    • 15
    • 15
    • 15
    • 14
    • 7
    • 7
    • 6
    • 6
    • 6
    • 6
    • 5
    • 5
    • 4
    • 3
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    C-Term

    Cross-Reactivity

    Human, Mouse, Rat

    Characteristics

    Rabbit Polyclonal antibody to VEGF (vascular endothelial growth factor A)
    VEGF antibody

    Purification

    Purified by antigen-affinity chromatography.

    Immunogen

    Recombinant protein encompassing a sequence within the C-terminus region of human VEGF. The exact sequence is proprietary.

    Isotype

    IgG
  • Application Notes

    WB: 1:500-1:3000. IHC-P: 1:100-1:1000. Optimal dilutions/concentrations should be determined by the researcher. Not tested in other applications.

    Comment

    Validation: Orthogonal

    Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    0.17 mg/mL

    Buffer

    1XPBS ( pH 7), 1 % BSA, 20 % Glycerol, 0.025 % ProClin 300

    Preservative

    ProClin

    Precaution of Use

    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    4 °C,-20 °C

    Storage Comment

    Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4°C. For long-term storage, aliquot and store at -20°C or below. Avoid multiple freeze-thaw cycles.
  • Chen, Guo, Guo, Kong, Bai, Long: "Protective Effect of Vitamin C against Infancy Rat Corneal Injury Caused by Acute UVB Irradiation." in: BioMed research international, Vol. 2020, pp. 8089273, (2020) (PubMed).

    Long, Yan, He, Zhang, Wang, Li, Xue, Chen, An, Zhang: "Protective effects of hydrogen gas in a rat model of branch retinal vein occlusion via decreasing VEGF-α expression." in: BMC ophthalmology, Vol. 19, Issue 1, pp. 112, (2019) (PubMed).

    Chen, Wang, Wei, Tzeng, Lan, Cheng, Kuo: "Maintenance BEZ235 Treatment Prolongs the Therapeutic Effect of the Combination of BEZ235 and Radiotherapy for Colorectal Cancer." in: Cancers, Vol. 11, Issue 8, (2019) (PubMed).

    Toraih, Ibrahiem, Fawzy, Hussein, Al-Qahtani, Shaalan: "MicroRNA-34a: A Key Regulator in the Hallmarks of Renal Cell Carcinoma." in: Oxidative medicine and cellular longevity, Vol. 2017, pp. 3269379, (2018) (PubMed).

    Kumarasamy, Sun: "Demonstration of a potent RET transcriptional inhibitor for the treatment of medullary thyroid carcinoma based on an ellipticine derivative." in: International journal of oncology, Vol. 51, Issue 1, pp. 145-157, (2018) (PubMed).

    Jiang, Li, Li, Fang, Long: "Dickkopf‑related protein 1 induces angiogenesis by upregulating vascular endothelial growth factor in the synovial fibroblasts of patients with temporomandibular joint disorders." in: Molecular medicine reports, Vol. 12, Issue 4, pp. 4959-66, (2016) (PubMed).

  • Target

    VEGFA (Vascular Endothelial Growth Factor A (VEGFA))

    Alternative Name

    vascular endothelial growth factor A

    Background

    This gene is a member of the PDGF/VEGF growth factor family and encodes a protein that is often found as a disulfide linked homodimer. This protein is a glycosylated mitogen that specifically acts on endothelial cells and has various effects, including mediating increased vascular permeability, inducing angiogenesis, vasculogenesis and endothelial cell growth, promoting cell migration, and inhibiting apoptosis. Elevated levels of this protein is linked to POEMS syndrome, also known as Crow-Fukase syndrome. Mutations in this gene have been associated with proliferative and nonproliferative diabetic retinopathy. Alternatively spliced transcript variants, encoding either freely secreted or cell-associated isoforms, have been characterized. There is also evidence for the use of non-AUG (CUG) translation initiation sites upstream of, and in-frame with the first AUG, leading to additional isoforms.

    Cellular Localization: Secreted

    Molecular Weight

    27 kDa

    Gene ID

    7422

    UniProt

    P15692

    Pathways

    RTK Signaling, Glycosaminoglycan Metabolic Process, Regulation of Cell Size, Tube Formation, Signaling Events mediated by VEGFR1 and VEGFR2, Platelet-derived growth Factor Receptor Signaling, VEGFR1 Specific Signals, VEGF Signaling
You are here:
Chat with us!